Throughout the year, Teva had momentum in innovative medicines, scaling its global generics and biosimilars portfolio. On the brand side, Teva said it continued to showcase strong performance of its ...

The Senate Republican campaign chair has a stark warning for his party as the GOP defends its 53-47 majority in the chamber in this year's midterm elections. National Republican Senatorial Committee ...

As the midterm election year gets underway, voters are already drawing clear lines between the Democratic and Republican parties on the issues. A new Fox News survey, released Thursday, finds the ...

As Dhurandhar continues to tell cinegoers that Pakistan’s deep state views Hindus as pushovers, Border 2 arrives to underscore that the 1971 War stemmed from the neighbour’s belief that Indians are ...

Democrats are ahead of Republicans by 6 percentage points on a generic congressional ballot, according to a poll released Thursday. In the Emerson College poll, 48.1 percent of respondents backed a ...

HYDERABAD, Jan 21 (Reuters) - Indian drugmaker Dr Reddy's (REDY.NS), opens new tab, which reported a smaller-than-expected fall in quarterly profit on Wednesday, said that it has received an approval ...

Prefilled drug delivery device specialist Apiject has signed a lease for a new site in Apex, North Carolina, that will house two blow-fill-seal production lines. The 30,000-square-foot facility will ...

British Columbians could soon have access to cheaper versions of injectable diabetes and obesity drugs. Health Canada is reviewing nine submissions for generic versions of semaglutide, a prescription ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...